Jeffrey Asphall

Jeffrey Asphall is a Medical Director in Drug Safety and Pharmacovigilance at BridgeBio since April 2024, previously serving as Sr. Global Safety Physician at Emergent BioSolutions from March 2022 to April 2024, where responsibilities included providing expertise on drug safety and regulatory compliance. Prior experience includes Associate Director of Field Medical Affairs at Regeneron, overseeing multiple states and providing insights on projects utilizing real-world data, Clinical Trial Director at CNS Healthcare focusing on development strategy and pharmacovigilance, and Clinical Trial Manager at Aspire Health Science, managing relationships and oversight for clinical trials across North America and Mexico. Jeffrey holds an MD from the University of Washington - School of Medicine and a BS in Chemistry from the University of South Florida.